ProjectIovance C-144-01
Basic data
Title:
Iovance C-144-01
Duration:
18/05/2018 to 17/05/2024
Abstract / short description:
A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma”, Protocol Number: C-144-01
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
San Carlos, Kalifornien, United States